202 related articles for article (PubMed ID: 10646898)
1. Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy.
Kawaguchi T; Yamamoto S; Naka N; Okishio K; Atagi S; Ogawara M; Hosoe S; Kawahara M; Furuse K
Br J Cancer; 2000 Jan; 82(2):418-23. PubMed ID: 10646898
[TBL] [Abstract][Full Text] [Related]
2. Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy.
Koukourakis MI; Corti L; Skarlatos J; Giatromanolaki A; Krammer B; Blandamura S; Piazza M; Verwanger T; Schnitzhofer G; Kostandelos J; Beroukas K
Anticancer Res; 2001; 21(1B):663-8. PubMed ID: 11299823
[TBL] [Abstract][Full Text] [Related]
3. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
6. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
[TBL] [Abstract][Full Text] [Related]
8. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
Allal AS; Waelchli L; Bründler MA
Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.
Koukourakis MI; Giatromanolaki A; Skarlatos J; Corti L; Blandamura S; Piazza M; Gatter KC; Harris AL
Cancer Res; 2001 Mar; 61(5):1830-2. PubMed ID: 11280732
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
14. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
Lung; 2001; 179(5):265-78. PubMed ID: 11976895
[TBL] [Abstract][Full Text] [Related]
15. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Kübler AC; de Carpentier J; Hopper C; Leonard AG; Putnam G
Int J Oral Maxillofac Surg; 2001 Dec; 30(6):504-9. PubMed ID: 11829232
[TBL] [Abstract][Full Text] [Related]
16. bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy.
Gallo O; Boddi V; Calzolari A; Simonetti L; Trovati M; Bianchi S
Clin Cancer Res; 1996 Feb; 2(2):261-7. PubMed ID: 9816168
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
18. In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.
Sikkink SK; Liloglou T; Maloney P; Gosney JR; Field JK
Int J Oncol; 2003 Mar; 22(3):589-95. PubMed ID: 12579312
[TBL] [Abstract][Full Text] [Related]
19. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
